The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in...
-
Upload
cordelia-stephens -
Category
Documents
-
view
219 -
download
1
Transcript of The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in...
![Page 1: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/1.jpg)
The clinical and economic impact of interventions to prevent loss to follow-up (LTFU) in resource-limited settings
Elena Losina, Hapsatou Touré, Lauren Uhler, Xavier Anglaret, A. David Paltiel, Eric Balestre,
Rochelle Walensky, Eugène Messou, Milton Weinstein, François Dabis, Kenneth Freedberg for the CEPAC
International and ART-LINC investigators
Supported by NIAID and the ANRS
![Page 2: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/2.jpg)
Background
• Nearly 4 million people have started ART
• 10-51% of patients in ART programs in Africa have been lost to follow up at one year
• Most interventions focus on patients lost after starting ART
• Many of these patients develop OIs or die before returning to care
![Page 3: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/3.jpg)
Background
• Preventing LTFU could be more effective than efforts to find patients
• No LTFU prevention studies have been reported from resource-limited settings– Questions of efficacy and cost
![Page 4: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/4.jpg)
Cost-effectiveness analysis and modeling
• Evaluating clinical trial results for policy
• “What if” analyses– Provide targets for efficacy and cost, before
studies are done– To understand how interventions might have a
role in HIV care
![Page 5: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/5.jpg)
Objective
• To conduct a “what if” analysis to project the survival gains and cost-effectiveness of interventions to prevent LTFU in Côte d’Ivoire
![Page 6: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/6.jpg)
Cost-effectiveness of Preventing AIDS Complications (CEPAC) International Model
• Detailed simulation model of HIV disease• Key elements of natural history and treatment• Outcome is the cost-effectiveness ratio
– a measure of value for money ($/YLS)
• “Value” highlighted by Stefano Bertozzi
![Page 7: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/7.jpg)
• WHO Commission on Macroeconomics and Health– If ratio <3x per capita GDP, cost-effective– If ratio <1x per capita GDP, “very” cost-effective– Côte d’Ivoire per capita GDP (2007) was $940– 3X GDP was $2820
What is a Cost-effective Intervention?
IMF 2007
![Page 8: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/8.jpg)
Clinical Data
• Aconda program, Côte d’Ivoire– CePReF, Abidjan, dedicated HIV treatment center
• 3,500 HIV-infected patients– 18 primary health centers, not HIV-specific
• 6,700 HIV-infected patients
• Mean CD4 at presentation: 140/μl• Cumulative LTFU 1 year after ART initiation
– 11% at CePReF– 18% in the primary health centers
Touré, AIDS 2008
![Page 9: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/9.jpg)
Cost Data
• Aconda program
• ART regimens– $60/year 1st-line NNRTI-based – $670/year 2nd-line PI-based
• Mean medical cost/person/year on ART $820
![Page 10: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/10.jpg)
Four LTFU Prevention Interventions
Intervention Individual
($/person/year)
Combined
($/person/year)
1. Elimination of ART co-payments
$22 $ 22
2. Providing OI medications free to patients
$19 $ 41
3. Increased training for health care workers
$12 $ 53
4. Transportation to clinic and breakfast
$24 $ 77
![Page 11: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/11.jpg)
Results: Projected Life Expectancy with HIV
12.06
0
2
4
6
8
10
12
14
No LTFU
Yea
rs
![Page 12: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/12.jpg)
Results: Projected Life Expectancy with HIV
12.06
5.70
0
2
4
6
8
10
12
14
No LTFU LTFU by 1 year
Yea
rs
![Page 13: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/13.jpg)
Results: Projected Life Expectancy with HIV
12.06
5.70
0
2
4
6
8
10
12
14
No LTFU LTFU by 1 year
Yea
rs
6.36
![Page 14: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/14.jpg)
Results: Years of Life Lost from LTFU in Aconda
• General health clinics
– 6,700 patients
– 18% LTFU at 1 year
– 6.36 years per person lost
– 6,700 X 18% X 6.36 years =
7,670 years of life lost
![Page 15: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/15.jpg)
Results: No ART co-payments, $22
StrategyLife
Expectancy (years)
Lifetime Costs
($)C-E Ratio ($/YLS)
No intervention 10.92 8,800 ---
$22 Intervention efficacy*
10% 11.03 9,100 3,100
25% 11.20 9,300 1,800
50% 11.49 9,600 1,400
75% 11.78 9,900 1,200
*% reduction in LTFU at 1 year (baseline LTFU = 18%)
![Page 16: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/16.jpg)
Results: Efficacy and Cost of the Interventions
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
10% 25% 50% 75% 90%
$77/year$53/year$41/year$22/year
3xGDP
Reduction in LTFU
Co
st-e
ffect
iven
ess
ra
tio (
$/Y
LS)
X
![Page 17: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/17.jpg)
Baseline Rates of LTFU
• Settings with highest rates of LTFU have the most to gain from effective interventions.
• Even in settings with moderate LTFU rates, interventions to decrease LTFU may be cost-effective.
![Page 18: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/18.jpg)
Limitations
• Costs were projected from estimates of interventions in Abidjan, not from tested interventions
• Analysis did not include:
– LTFU after the 1st year
– Sustainability
• 3X GDP threshold:
– International commitment and partnerships in HIV care and financing
![Page 19: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/19.jpg)
Conclusions
• Loss to follow-up from HIV treatment programs in resource-limited settings results in substantial decreases in life expectancy.
• Interventions to prevent LTFU in these settings, if moderately effective, would be cost-effective by international criteria.
![Page 20: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/20.jpg)
The ART-LINC Collaboration of IeDEA
PrincipaI investigators: François Dabis, Matthias Egger, Mauro Schechter
Central Team: Eric Balestre, Martin Brinkhof, Claire Graber, Olivia Keiser, Catherine Seyler, Hapsatou Touré, Charlotte Lewden
Steering Group: Kathryn Anastos (Kigali); David Bangsberg (Mbarara/ Kampala); Andrew Boulle (Cape Town); Jennipher Chisanga (Lusaka); Eric Delaporte (Dakar); Diana Dickinson (Gaborone); Ernest Ekong (Lagos); Kamal Marhoum El Filali (Casablanca); Mina Hosseinipour (Lilongwe); Silvester Kimaiyo (Eldoret); Mana Khongphatthanayothin (Bangkok); N Kumarasamy (Chennai); Christian Laurent (Yaounde); Ruedi Luthy (Harare); James McIntyre (Johannesburg); Timothy Meade (Lusaka); Eugene Messou (Abidjan); Denis Nash (New York); Winstone Nyandiko Mokaya (Eldoret); Margaret Pascoe (Harare); Larry Pepper (Mbarara); Papa Salif Sow (Dakar); Sam Phiri (Lilongwe); Mauro Schechter (Rio de Janeiro); John Sidle (Eldoret); Eduardo Sprinz (Porto Alegre); Besigin Tonwe-Gold (Abidjan); Siaka Touré (Abidjan); Stefaan Van der Borght (Amsterdam); Ralf Weigel (Lilongwe); Robin Wood (Cape Town)
![Page 21: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/21.jpg)
The CEPAC International TeamUnited StatesElena Losina, PhDRochelle Walensky, MD, MPHMelissa Bender, MDJohn Chiosi, BSAndrea Ciaranello, MD, MPHJennifer Chu, BScKenneth Freedberg, MD, MScSue Goldie, MD, MPHApril Kimmel, MScJulie Levison, MD, MPhilBethany Morris, BAA. David Paltiel, PhDMai Pho, MDErin Rhode, MSCallie Scott, MScGeorge Seage, III, PhDCaroline Sloan, ABAdam Stoler, MALauren Uhler, BAMilton Weinstein, PhD
Côte d’IvoireXavier Anglaret, MD, PhDEugène Messou, MDCatherine Seyler, MD, MScChristine Danel, MD, PhDEric Ouattara, MD, MPHSiaka Touré, MD, MPHHapsatou Touré, MD, MPH
FranceYazdan Yazdanpanah, MD, PhDSylvie Deuffic-Burban, PhDDelphine Gabillard, PhD
South AfricaNeil Martinson, MBBCh, MPHRobin Wood, MD
IndiaNagalingeswaran Kumarasamy, MDKenneth Mayer, MDSoumya Swaminathan, MD
Supported by NIAID and the ANRS
![Page 22: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/22.jpg)
![Page 23: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/23.jpg)
Results: Efficacy and Cost of the Interventions
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
10% 25% 50% 75% 90%
$77/year$53/year$41/year$22/year
3xGDP
Reduction in LTFU
Co
st-e
ffect
iven
ess
ra
tio (
$/Y
LS)
![Page 24: The clinical and economic impact of interventions to prevent loss to follow- up (LTFU) in resource-limited settings Elena Losina, Hapsatou Touré, Lauren.](https://reader036.fdocuments.net/reader036/viewer/2022062321/56649ed05503460f94bde2a4/html5/thumbnails/24.jpg)
• Two different outcome measures
– Cost: $, other currency
– Effectiveness: years of life saved (YLS) or quality-adjusted life-years (QALYs)
• Cost-effectiveness ratio:
Additional Resource Use
Additional Health Benefits
• Represents the value of resources spent ($/YLS)
Cost-effectiveness Analysis